Association between nintedanib adherence trajectory and healthcare use among idiopathic pulmonary fibrosis patients.

Saved in:
Bibliographic Details
Title: Association between nintedanib adherence trajectory and healthcare use among idiopathic pulmonary fibrosis patients.
Authors: Nili M; Boehringer Ingelheim Pharmaceuticals, Inc, 900 Ridgebury Rd, 06877, Ridgefield, CT, USA. mona.nili@boehringer-ingelheim.com., Epstein AJ; Medicus Economics, Milton, MA, USA., Nunag D; Medicus Economics, Milton, MA, USA., Olson A; Boehringer Ingelheim Pharmaceuticals, Inc, 900 Ridgebury Rd, 06877, Ridgefield, CT, USA., Borah BJ; Mayo Clinic, Rochester, MN, USA.
Source: BMC pulmonary medicine [BMC Pulm Med] 2024 Mar 19; Vol. 24 (1), pp. 141. Date of Electronic Publication: 2024 Mar 19.
Publication Type: Journal Article
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100968563 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2466 (Electronic) Linking ISSN: 14712466 NLM ISO Abbreviation: BMC Pulm Med Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1471-2466
DOI:10.1186/s12890-024-02929-7